Document is current
Any future updates will be listed below
-
Authors
Kanaoka, Haruka
Nagahashi, Masayuki https://orcid.org/0000-0003-3462-253X
Tsuchida, Junko
Kuroiwa, Mamiko
Urano, Sayaka
Komatsu, Miki
Yoshida, Shoko
Oshiro, Aoi
Sugimoto, Gen
Mitsuyoshi, Ayumu
Togashi, Yusa
Hattori, Akira
Higuchi, Tomoko
Nishimukai, Arisa
Shimoda, Masafumi
Miyoshi, Yasuo
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (25K02712)
Japan Society for the Promotion of Science (24K11775)
Japan Society for the Promotion of Science (24K11755)
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 2 February 2026
First Online: 23 February 2026
Declarations
:
: M Nagahashi received honoraria from Chugai, AstraZeneca, Eli Lilly, Pfizer, Novartis, MSD, Taiho, Daiichi Sankyo, Eisai, Kyowa-Kirin, and Denka. Y Miyoshi received research funding and honoraria from Eisai, Chugai, AstraZeneca, Eli Lilly, Pfizer, MSD, Kyowa-Kirin, Daiichi Sankyo, and Taiho. M Shimoda received honoraria from Chugai, Pfizer, MSD, Eisai, Eli Lilly, Daiichi Sankyo, and AstraZeneca. H Kanaoka, M Kuroiwa, S Urano, M Komatsu, S Yoshida, A Oshiro, G Sugimoto, A Mitsuyoshi, Y Togashi, A Hattori, J Tsuchida, T Higuchi, and A Nishimukai declare no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
